![](https://cbmm.bwh.harvard.edu/wp-content/uploads/2023/11/f1d7bcae6eb431250aa60fec39b6513b.jpg)
Learn about new treatments, how they work, who is eligible to receive them, what is covered by insurance and potential side effects.
New Treatments for Alzheimer’s disease: Why Early Diagnosis is Important
Friday, December 1st, 12-1PM via Zoom
Presented by:
- Gad Marshall, MD – Director of Clinical Trials at the BWH Center for Alzheimer Research and Treatment (CART)
- Dorene Rentz, PsyD – Co-Director, Outreach, Recruitment & Engagement Core at MADRC, Co-Director of CART
- Christine Ritchie, MD, MSPH – Co-Director, Outreach, Recruitment & Engagement Core at MADRC
- Mike Erkkinen, MD – Director BWH Division of Cognitive & Behavioral Neurology
- John Dickson, MD, PhD – Neurologist, MGH Memory Disorders Division
- Art Canter – Research Participant at MADRC
This program will explain:
- How lecanemab works & potential side effects
- Who could benefit from this new medication
- Treatment costs & insurance coverage options
- How patients may access the medication at MGB
This program will be presented virtually by the Massachusetts Alzheimer’s Disease Research Center (MADRC). To learn more about our work: www.madrc.org.